FDA NEWS

FDA: Time for Asthma Patients to Get New Inhalers - ABC News
Old-fashioned asthma inhalers that contain environment-harming chemicals will quit selling at year's end — and the government is urging patients not to wait until the last minute to switch to newer alternatives. Patients use inhalers that dispense
Source: www.abcnews.go.com

FDA panel favors Glaxo, Ligand blood drug - Forbes
Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline PLC and Ligand Pharmaceuticals Inc. is effective for short-term use, despite reservations by FDA scientists. A panel of 16 outside advisers voted
Source: www.forbes.com

FDA panel says data backs use of Glaxo's Promacta - Forbes
CHICAGO (Reuters) - An expert advisory panel to the U.S. Food and Drug Administration said Friday that current clinical data supports short-term use of GlaxoSmithKline (nyse: GSK - news - people ) Plc's experimental platelet-boosting drug, Promacta
Source: www.forbes.com

Tainted Drug Imports Set Off Warnings, Not FDA Action (Update2) - Bloomberg
May 30 (Bloomberg) -- Two Americans died and 15 suffered seizures. The suspected cause: The epilepsy medicine they depended on stopped working because of a counterfeit ingredient from overseas. The case of the flawed drug, made by a company that no
Source: www.bloomberg.com

UPDATE 1-FDA panel says data backs use of Glaxo's Promacta - Reuters
CHICAGO, May 30 (Reuters) - An expert advisory panel to the U.S. Food and Drug Administration said on Friday that current clinical data supports short-term use of GlaxoSmithKline Plc's (GSK.L: Quote , Profile , Research )(GSK.N: Quote , Profile
Source: www.reuters.com

State to share in Vioxx accord - Baltimore Sun
Merck & Co. has agreed to pay $58 million to multiple states, including Maryland, to settle allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. The agreement announced yesterday also calls for
Source: www.baltimoresun.com

FDA: Time for asthma patients to switch inhalers - Salon
May 30th, 2008 | WASHINGTON -- Old-fashioned asthma inhalers that contain environment-harming chemicals will no longer be sold at year's end — and the government is urging patients not to wait until the last minute to switch to newer alternatives
Source: www.salon.com

Lupin receives USFDA nod for Topiramate tablets - MyIris
Lupin , leading drugmaker received tentative approval for its abbreviated new drug application (ANDA) for Topiramate tablets, 25 mg, 50mg, 100mg and 200 from the US Food and Drug Administration (US FDA). Lapin`s Topiramate tablets are the AB rated
Source: www.myiris.com

FDA panel favors Glaxo, Ligand blood drug - Los Angeles Times
WASHINGTON -- Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline PLC and Ligand Pharmaceuticals Inc. is effective for short-term use, despite reservations by FDA scientists. A panel of 16 outside
Source: www.latimes.com